{"id":690567,"date":"2022-09-29T17:23:08","date_gmt":"2022-09-29T21:23:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/"},"modified":"2022-09-29T17:23:08","modified_gmt":"2022-09-29T21:23:08","slug":"helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/","title":{"rendered":"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWTOWN, Pa., Sept.  29, 2022  (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference, as follows:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%;vertical-align: middle\">Date:<\/td>\n<td style=\"max-width:80%;width:80%;min-width:80%;vertical-align: middle\">Thursday, October 6, 2022<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">\u00a0<\/td>\n<td style=\"vertical-align: middle\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">Time:<\/td>\n<td style=\"vertical-align: middle\">8:45 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">\u00a0<\/td>\n<td style=\"vertical-align: middle\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle\">Location:<\/td>\n<td style=\"vertical-align: middle\">The Yale Club, New York, NY<\/td>\n<\/tr>\n<\/table>\n<p>Investors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact their Roth Capital representative to arrange a meeting.\u00a0<\/p>\n<p>\n        <strong>About Helius Medical Technologies, Inc.<\/strong><br \/>\n        <br \/>Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using non-implantable platform technologies that amplify the brain\u2019s ability to compensate and promote neuroplasticity, improving the lives of people dealing with neurologic diseases.<\/p>\n<p>The Company\u2019s first commercial product is the Portable Neuromodulation Stimulator (PoNS\u00ae). For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BCOQOGhQt2NtzCPA767ohGNPi-mQehM1j4AM0x4Te5uHryiI2JjoEoE5o9PLZKEYIA_2vwGmIUQPReEIPEe4nqa44YUUYhV9AnSdRK86-_M=\" rel=\"nofollow noopener\" target=\"_blank\">www.heliusmedical.com<\/a>.<\/p>\n<p>\n        <strong>About the PoNS Device and PoNS Therapy<\/strong><br \/>\n        <br \/>The Portable Neuromodulation Stimulator (PoNS) is an innovative non-surgical medical device, inclusive of a controller and mouthpiece, which delivers electrical stimulation to the surface of the tongue to improve balance and gait. The PoNS device is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (\u201cMS\u201d) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. Helius is advancing PoNS post-approval research in MS through a recently launched Therapeutic Experience Program (TEP) designed to partner with neurologists and neurorehabilitation therapists at 10-12 US centers of excellence, who express an interest in becoming \u201cearly adopters\u201d of PoNS therapy. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2nA7uvtCLNEYgICyQc0s-pzbCwI3DH3B9HTZ3lNFNR4P1HRqGIr5-uu9NY1LyXeAAdQWAZ21DhRN8FvqOUeMNXXOKHdZdclXjucl0-rOjq8=\" rel=\"nofollow noopener\" target=\"_blank\">www.ponstherapy.com<\/a>.<\/p>\n<p>PoNS is also authorized for sale in Canada for two indications: (i) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (\u201cmmTBI\u201d) and is to be used in conjunction with physical therapy; and (ii) for use as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy. PoNS is also authorized for sale in Australia for short term use by healthcare professionals as an adjunct to a therapeutic exercise program to improve balance and gait.<\/p>\n<p>\n        <strong>Investor Relations Contact<\/strong><br \/>\n        <br \/>Lisa M. Wilson, In-Site Communications, Inc.<br \/>T: 212-452-2793<br \/>E: lwilson@insitecony.com<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OGZjZDBmMGUtOTJlNy00ZTEyLTgxNTctZTNjMzgxODM3ZjFiLTEwOTM2MDI=\/tiny\/Helius-Medical-Technologies-In.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference, as follows: Date: Thursday, October 6, 2022 \u00a0 \u00a0 Time: 8:45 AM ET \u00a0 \u00a0 Location: The Yale Club, New York, NY Investors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact their Roth Capital representative to arrange a meeting.\u00a0 About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-690567","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference, as follows: Date: Thursday, October 6, 2022 \u00a0 \u00a0 Time: 8:45 AM ET \u00a0 \u00a0 Location: The Yale Club, New York, NY Investors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact their Roth Capital representative to arrange a meeting.\u00a0 About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic &hellip; Continue reading &quot;Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T21:23:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference\",\"datePublished\":\"2022-09-29T21:23:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/\"},\"wordCount\":422,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/\",\"name\":\"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=\",\"datePublished\":\"2022-09-29T21:23:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/","og_locale":"en_US","og_type":"article","og_title":"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference - Market Newsdesk","og_description":"NEWTOWN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference, as follows: Date: Thursday, October 6, 2022 \u00a0 \u00a0 Time: 8:45 AM ET \u00a0 \u00a0 Location: The Yale Club, New York, NY Investors and attendees who would like to schedule a 1-on-1 meeting with Helius management are asked to contact their Roth Capital representative to arrange a meeting.\u00a0 About Helius Medical Technologies, Inc. Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic &hellip; Continue reading \"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-29T21:23:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference","datePublished":"2022-09-29T21:23:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/"},"wordCount":422,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/","name":"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=","datePublished":"2022-09-29T21:23:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1NjI1NyM1MTc5OTY2IzIwODIwMzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-to-present-at-the-roth-capital-partners-inaugural-healthcare-opportunities-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=690567"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690567\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=690567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=690567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=690567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}